Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more
Amoeba SA (ALMIB) - Net Assets
Latest net assets as of June 2025: €-14.27 Million EUR
Based on the latest financial reports, Amoeba SA (ALMIB) has net assets worth €-14.27 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€6.37 Million) and total liabilities (€20.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-14.27 Million |
| % of Total Assets | -223.92% |
| Annual Growth Rate | N/A |
| 5-Year Change | -620.38% |
| 10-Year Change | -98322.14% |
| Growth Volatility | 21494.12 |
Amoeba SA - Net Assets Trend (2011–2024)
This chart illustrates how Amoeba SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Amoeba SA (2011–2024)
The table below shows the annual net assets of Amoeba SA from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €-10.41 Million | -163.94% |
| 2023-12-31 | €-3.94 Million | -148.31% |
| 2022-12-31 | €8.16 Million | +4008.99% |
| 2021-12-31 | €198.68K | -90.07% |
| 2020-12-31 | €2.00 Million | -52.68% |
| 2019-12-31 | €4.23 Million | +78041.99% |
| 2018-12-31 | €5.41K | -56.79% |
| 2017-12-31 | €12.52K | -32.78% |
| 2016-12-31 | €18.63K | +75.75% |
| 2015-12-31 | €10.60K | -99.62% |
| 2014-12-31 | €2.80 Million | +544.95% |
| 2013-12-31 | €433.99K | -54.18% |
| 2012-12-31 | €947.20K | +58.55% |
| 2011-12-31 | €597.42K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Amoeba SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 622867600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €993.20K | % |
| Other Comprehensive Income | €-17.93 Million | % |
| Other Components | €13.12 Million | % |
| Total Equity | €-10.41 Million | 100.00% |
Amoeba SA Competitors by Market Cap
The table below lists competitors of Amoeba SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AGILYX ASA NK -02
F:5NQ
|
$58.32 Million |
|
R&B FOOD SUPPLY
BK:RBF-R
|
$58.33 Million |
|
We & Win Development Co Ltd
TW:2537
|
$58.35 Million |
|
Aminologics Co.Ltd
KQ:074430
|
$58.36 Million |
|
Noroo Paint
KO:090350
|
$58.27 Million |
|
Columbus A/S
CO:COLUM
|
$58.26 Million |
|
DAM CAPITAL ADVISORS LTD
NSE:DAMCAPITAL
|
$58.25 Million |
|
Skyline Bankshares Inc.
OTCQX:SLBK
|
$58.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Amoeba SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -3,944,125 to -10,410,083, a change of -6,465,958.
- Net loss of 6,591,504 reduced equity.
- Share repurchases of 6,429,600 reduced equity.
- Other comprehensive income decreased equity by 14,172,469.
- Other factors increased equity by 20,727,615.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-6.59 Million | -63.32% |
| Share Repurchases | €6.43 Million | -61.76% |
| Other Comprehensive Income | €-14.17 Million | -136.14% |
| Other Changes | €20.73 Million | +199.11% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Amoeba SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €0.25 | €1.10 | x |
| 2013-12-31 | €0.12 | €1.10 | x |
| 2014-12-31 | €0.74 | €1.10 | x |
| 2015-12-31 | €2.36 | €1.10 | x |
| 2016-12-31 | €3.23 | €1.10 | x |
| 2017-12-31 | €2.09 | €1.10 | x |
| 2018-12-31 | €0.90 | €1.10 | x |
| 2019-12-31 | €0.54 | €1.10 | x |
| 2020-12-31 | €0.12 | €1.10 | x |
| 2021-12-31 | €0.01 | €1.10 | x |
| 2022-12-31 | €0.24 | €1.10 | x |
| 2023-12-31 | €-0.08 | €1.10 | x |
| 2024-12-31 | €-0.21 | €1.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Amoeba SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1095.66%
- • Asset Turnover: 0.11x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-388.09%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -26.07% | -302.90% | 0.05x | 1.81x | €-341.64K |
| 2013 | -120.07% | -172.43% | 0.14x | 5.15x | €-564.49K |
| 2014 | -34.82% | -438.07% | 0.04x | 1.98x | €-1.25 Million |
| 2015 | -37.92% | -2851.48% | 0.01x | 1.33x | €-5.08K |
| 2016 | -30.96% | -4579.41% | 0.01x | 1.25x | €-7.63K |
| 2017 | -49.79% | -3865.77% | 0.01x | 1.72x | €-7.49K |
| 2018 | -133.48% | -5907.34% | 0.01x | 2.57x | €-7.76K |
| 2019 | -171.48% | -5919.10% | 0.01x | 3.27x | €-7.67 Million |
| 2020 | -407.76% | 0.00% | 0.00x | 6.53x | €-8.36 Million |
| 2021 | -3934.54% | 0.00% | 0.00x | 72.99x | €-7.84 Million |
| 2022 | -98.27% | 0.00% | 0.00x | 1.52x | €-8.84 Million |
| 2023 | 0.00% | -2152.31% | 0.11x | 0.00x | €-13.90 Million |
| 2024 | 0.00% | -1095.66% | 0.11x | 0.00x | €-5.55 Million |
Industry Comparison
This section compares Amoeba SA's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $21,677,000
- Average return on equity (ROE) among peers: 6.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Amoeba SA (ALMIB) | €-14.27 Million | -26.07% | N/A | $58.28 Million |
| Florentaise SA (ALFLO) | $33.11 Million | -0.08% | 2.06x | $236.06K |
| Graines Voltz S.A (GRVO) | $10.24 Million | 12.76% | 1.52x | $11.58 Million |